The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Selective CXCR4 antagonism by Tat: Implications for in vivo expansion of coreceptor use by HIV-1
Open accessAbstract
Chemokines and chemokine receptors play important roles in HIV-1 infection and tropism. CCR5 is the major macrophage-tropic coreceptor for HIV-1 whereas CXC chemokine receptor 4 (CXCR4) serves the counterpart function for T cell-tropic viruses. An outstanding biological mystery is why only R5-HIV-1 is initially detected in new seroconvertors who are exposed to R5 and X4 viruses. Indeed, X4 virus emerges in a minority of patients and only in the late stage of disease, suggesting that early negative selection against HIV-1–CXCR4 interaction may exist. Here, we report that the HIV-1 Tat protein, which is secreted from virus-infected cells, is a CXCR4-specific antagonist. Soluble Tat selectively inhibited the entry and replication of X4, but not R5, virus in peripheral blood mononuclear cells (PBMCs). We propose that one functional consequence of secreted Tat is to select against X4 viruses, thereby influencing the early in vivo course of HIV-1 disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor
Feng, Y., Broder, C. C., Kennedy, P. E., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5263.872 · Cited by 4,172
Identification of a major co-receptor for primary isolates of HIV-1
Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Marzio, P. D., Marmon, S., Sutton, R. E., Hill, C. M., et al. (1996) · Nature · doi:10.1038/381661a0 · Cited by 3,641
HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time
Perelson, A. S., Neumann, A. U., Markowitz, M., Leonard, J. M., & Ho, D. D. (1996) · Science · doi:10.1126/science.271.5255.1582 · Cited by 3,531
HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
Dragic, T., Litwin, V., Allaway, G. P., Martin, S. R., Huang, Y., Nagashima, K. A., Cayanan, C., Maddon, P. J., Koup, R. A., Moore, J. P., et al. (1996) · Nature · doi:10.1038/381667a0 · Cited by 3,174
Cocchi, F., DeVico, A. L., Garzino-Demo, A., Arya, S. K., Gallo, R. C., & Lusso, P. (1995) · Science · doi:10.1126/science.270.5243.1811 · Cited by 2,869
CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1
Alkhatib, G., Combadiere, C., Broder, C. C., Feng, Y., Kennedy, P. E., Murphy, P. M., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5270.1955 · Cited by 2,706
Self-citationThe β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates
Choe, H., Farzan, M., Sun, Y., Sullivan, N., Rollins, B., Ponath, P. D., Wu, L., Mackay, C. R., LaRosa, G., Newman, W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81313-6 · Cited by 2,287
Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease
Berger, E. A., Murphy, P. M., & Farber, J. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.657 · Cited by 2,180
Self-citationDoranz, B. J., Rucker, J., Yi, Y., Smyth, R. J., Samson, M., Peiper, S. C., Parmentier, M., Collman, R. G., & Doms, R. W. (1996) · Cell · doi:10.1016/s0092-8674(00)81314-8 · Cited by 1,833
Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected Individuals
Connor, R. I., Sheridan, K. E., Ceradini, D., Choe, S., & Landau, N. R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.4.621 · Cited by 1,353
Genotypic and Phenotypic Characterization of HIV-1 Patients with Primary Infection
Zhu, T., Mo, H., Wang, N., Nam, D. S., Cao, Y., Koup, R. A., & Ho, D. D. (1993) · Science · doi:10.1126/science.8356453 · Cited by 1,249
Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120
Westendorp, M. O., Frank, R., Ochsenbauer, C., Stricker, K., Dhein, J., Walczak, H., Debating, K.-M., & Krammer, P. H. (1995) · Nature · doi:10.1038/375497a0 · Cited by 975
Ensoli, B., Barillari, G., Salahuddin, S. Z., Gallo, R. C., & Wong-Staal, F. (1990) · Nature · doi:10.1038/345084a0 · Cited by 896
A new classification for HIV-1
Berger, E. A., Doms, R. W., Fenyö, E.-M., Korber, B. T. M., Littman, D. R., Moore, J. P., Sattentau, Q. J., Schuitemaker, H., Sodroski, J., & Weiss, R. A. (1998) · Nature · doi:10.1038/34571 · Cited by 830
Tersmette, M., de Goede, R. E., Al, B. J., Winkel, I. N., Gruters, R. A., Cuypers, H. T., Huisman, H. G., & Miedema, F. (1988) · Journal of Virology · doi:10.1128/jvi.62.6.2026-2032.1988 · Cited by 595
Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4
Schols, D., Struyf, S., Damme, J. V., Esté, J. A., Henson, G., & Clercq, E. D. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1383 · Cited by 554
Cocchi, F., DeVico, A. L., Garzino-Demo, A., Cara, A., Gallo, R. C., & Lusso, P. (1996) · Nature Medicine · doi:10.1038/nm1196-1244 · Cited by 495
Multifaceted Activities of the HIV-1 Transactivator of Transcription, Tat
Jeang, K.-T., Xiao, H., & Rich, E. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.41.28837 · Cited by 414
Self-citationRichman, D. D., & Bozzette, S. A. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.5.968 · Cited by 401
A Small Molecule CXCR4 Inhibitor that Blocks T Cell Line–tropic HIV-1 Infection
Murakami, T., Nakajima, T., Koyanagi, Y., Tachibana, K., Fujii, N., Tamamura, H., Yoshida, N., Waki, M., Matsumoto, A., Yoshie, O., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1389 · Cited by 398
Doranz, B. J., Grovit-Ferbas, K., Sharron, M. P., Mao, S.-H., Goetz, M. B., Daar, E. S., Doms, R. W., & O'Brien, W. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1395 · Cited by 336
The neglected role of type I interferon in the T-cell response: implications for its clinical use
Belardelli, F., & Gresser, I. (1996) · Immunology Today · doi:10.1016/0167-5699(96)10027-x · Cited by 299
Combadiere, C., Ahuja, S. K., Lee Tiffany, H., & Murphy, P. M. (1996) · Journal of Leukocyte Biology · doi:10.1002/jlb.60.1.147 · Cited by 292
Self-citationControl of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine
Cafaro, A., Caputo, A., Fracasso, C., Maggiorella, M. T., Goletti, D., Baroncelli, S., Pace, M., Sernicola, L., Koanga-Mogtomo, M. L., Betti, M., et al. (1999) · Nature Medicine · doi:10.1038/9488 · Cited by 276
Transplantation of discordant xenografts: a challenge revisited
Parker, W., Saadi, S., Lin, S. S., Holzknecht, Z. E., Bustos, M., & Platt, J. L. (1996) · Immunology Today · doi:10.1016/0167-5699(96)10028-1 · Cited by 254
Identification of CCR8: A Human Monocyte and Thymus Receptor for the CC Chemokine I-309
Tiffany, H. L., Lautens, L. L., Gao, J.-L., Pease, J., Locati, M., Combadiere, C., Modi, W., Bonner, T. I., & Murphy, P. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.1.165 · Cited by 232
Self-citationAngiogenic properties of human immunodeficiency virus type 1 Tat protein.
Albini, A., Barillari, G., Benelli, R., Gallo, R. C., & Ensoli, B. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4838 · Cited by 210
Indicator Cell Lines for Detection of Primary Strains of Human and Simian Immunodeficiency Viruses
Vodicka, M. A., Goh, W. C., Wu, L. I., Rogel, M. E., Bartz, S. R., Schweickart, V. L., Raport, C. J., & Emerman, M. (1997) · Virology · doi:10.1006/viro.1997.8606 · Cited by 207
Yi, Y., Rana, S., Turner, J. D., Gaddis, N., & Collman, R. G. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.772-777.1998 · Cited by 176
Huang, L., Bosch, I., Hofmann, W., Sodroski, J., & Pardee, A. B. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8952-8960.1998 · Cited by 172
Xiao, L., Owen, S. M., Goldman, I. F., Lal, A. A., deJong, J. J., Goudsmit, J., & Lal, R. B. (1998) · Virology · doi:10.1006/viro.1997.8924 · Cited by 150
Gallo, R. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8324 · Cited by 145
Chesebro, B. W., Wehrly, K., Nishio, J., & Perryman, S. (1996) · Journal of Virology · doi:10.1128/jvi.70.12.9055-9059.1996 · Cited by 140
HIV-1 entry inhibitors: Evading the issue
Michael, N. L., & Moore, J. P. (1999) · Nature Medicine · doi:10.1038/10462 · Cited by 135
Secchiero, P., Zella, D., Capitani, S., Gallo, R. C., & Zauli, G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.2427 · Cited by 132
CXCR4 and CCR5 Expression Delineates Targets for HIV-1 Disruption of T Cell Differentiation
Berkowitz, R. D., Beckerman, K., Schall, T. J., & McCune, J. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3702 · Cited by 112
Esté, J. A., Cabrera, C., Clercq, E. D., Struyf, S., Damme, J. V., Bridger, G. J., Skerlj, R. T., Abrams, M. J., Henson, G. W., Gutiérrez, A., et al. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23157-6 · Cited by 101
Neuveut, C., & Jeang, K. T. (1996) · Journal of Virology · doi:10.1128/jvi.70.8.5572-5581.1996 · Cited by 79
Self-citationInhibition of CXCR4-Dependent HIV-1 Infection by Extracellular HIV-1 Tat
Ghezzi, S., Noonan, D. M., Aluigi, M. G., Vallanti, G., Cota, M., Benelli, R., Morini, M., Reeves, J. D., Vicenzi, E., Poli, G., et al. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2523 · Cited by 77
Macrophage Inflammatory Protein-1β Induces Migration and Activation of Human Thymocytes
Dairaghi, D. J., Franz-Bacon, K., Callas, E., Cupp, J. E., Schall, T. J., Tamraz, S., Boehme, S. A., Taylor, N. N., & Bacon, K. B. (1998) · Blood · doi:10.1182/blood.v91.8.2905.2905_2905_2913 · Cited by 59
Smith, S. M., Markham, R. B., & Jeang, K. T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7955 · Cited by 42
Self-citationEpithelin/Granulin Growth Factors: Extracellular Cofactors for HIV-1 and HIV-2 Tat Proteins
Trinh, D. P., Brown, K. M., & Jeang, K.-T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0317 · Cited by 29
Self-citation
Cited by
Cell Membrane Lipid Rafts Mediate Caveolar Endocytosis of HIV-1 Tat Fusion Proteins
Fittipaldi, A., Ferrari, A., Zoppé, M., Arcangeli, C., Pellegrini, V., Beltram, F., & Giacca, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303045200 · Cited by 475
Delivery of bioactive molecules into the cell: the Trojan horse approach
Dietz, G. P. H., & Bähr, M. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.03.005 · Cited by 469
Viral exploitation and subversion of the immune system through chemokine mimicry
Murphy, P. M. (2001) · Nature Immunology · doi:10.1038/84214 · Cited by 336
Self-citationBreaking down the barrier: The effects of HIV-1 on the blood–brain barrier
Strazza, M., Pirrone, V., Wigdahl, B., & Nonnemacher, M. R. (2011) · Brain Research · doi:10.1016/j.brainres.2011.05.015 · Cited by 218
András, I. E., Pu, H., Tian, J., Deli, M. A., Nath, A., Hennig, B., & Toborek, M. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600115 · Cited by 121
Metadata
- Authors
- Xiao, H., Neuveut, C., Tiffany, H. L., Benkirane, M., Rich, E. A., Murphy, P. M., & Jeang, K.-T.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2000-10-10
- Volume
- 97
- Issue
- 21
- Pages
- 11466-11471
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2067592236
- Cited by
- 368
- References
- 42
- FWCI
- 4.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.